Listed

Halozyme Therapeutics, Inc.

HALONasdaqCIK 1159036HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$481.0m, Q2 FY2026
Operating income$287.7m, Q2 FY2026
Net income$229.9m, Q2 FY2026
Halozyme Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m216Revenue, Q3 FY2023, three months to 2023-09-30$216.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure230Revenue, Q4 FY2023, three months to 2023-12-31$230.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure196Revenue, Q1 FY2024, three months to 2024-03-31$195.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure231Revenue, Q2 FY2024, three months to 2024-06-30$231.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure290Revenue, Q3 FY2024, three months to 2024-09-30$290.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure298Revenue, Q4 FY2024, three months to 2024-12-31$298.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure265Revenue, Q1 FY2025, three months to 2025-03-31$264.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure326Revenue, Q2 FY2025, three months to 2025-06-30$325.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure354Revenue, Q3 FY2025, three months to 2025-09-30$354.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure452Revenue, Q4 FY2025, three months to 2025-12-31$451.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure377Revenue, Q1 FY2026, three months to 2026-03-31$376.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure481Revenue, Q2 FY2026, three months to 2026-06-30$481.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Cost of revenue$m54.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$54.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure52.3Cost of revenue, Q4 FY2023, three months to 2023-12-31$52.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure28.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$28.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure39.6Cost of revenue, Q2 FY2024, three months to 2024-06-30$39.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure49.4Cost of revenue, Q3 FY2024, three months to 2024-09-30$49.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure42.1Cost of revenue, Q4 FY2024, three months to 2024-12-31$42.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure48.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$48.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure46.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$46.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure55.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$55.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure78.8Cost of revenue, Q4 FY2025, three months to 2025-12-31$78.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure79.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$79.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure79.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$79.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m17.3Research and development, Q3 FY2023, three months to 2023-09-30$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure21.3Research and development, Q4 FY2023, three months to 2023-12-31$21.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-18, accession 0001159036-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure19.1Research and development, Q1 FY2024, three months to 2024-03-31$19.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure21.0Research and development, Q2 FY2024, three months to 2024-06-30$21.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure18.5Research and development, Q3 FY2024, three months to 2024-09-30$18.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure20.4Research and development, Q4 FY2024, three months to 2024-12-31$20.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-18, accession 0001159036-25-000010. Derived: 12-month figure less the 9-month figure.Report this figure14.8Research and development, Q1 FY2025, three months to 2025-03-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure17.5Research and development, Q2 FY2025, three months to 2025-06-30$17.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure17.3Research and development, Q3 FY2025, three months to 2025-09-30$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figurenot reported25.6Research and development, Q1 FY2026, three months to 2026-03-31$25.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure27.7Research and development, Q2 FY2026, three months to 2026-06-30$27.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Selling, general and administrative$m35.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$35.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure37.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$37.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure35.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$35.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure35.7Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$35.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure41.2Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$41.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure42.2Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$42.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure42.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$42.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure41.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$41.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure46.1Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$46.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure77.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$77.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure57.9Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$57.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure57.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$57.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Operating income$m88.3Operating income, Q3 FY2023, three months to 2023-09-30$88.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure101Operating income, Q4 FY2023, three months to 2023-12-31$101.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure95.5Operating income, Q1 FY2024, three months to 2024-03-31$95.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure117Operating income, Q2 FY2024, three months to 2024-06-30$117.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure163Operating income, Q3 FY2024, three months to 2024-09-30$163.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure176Operating income, Q4 FY2024, three months to 2024-12-31$175.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure142Operating income, Q1 FY2025, three months to 2025-03-31$141.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure202Operating income, Q2 FY2025, three months to 2025-06-30$202.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure218Operating income, Q3 FY2025, three months to 2025-09-30$217.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure(92.9)Operating income, Q4 FY2025, three months to 2025-12-31−$92.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure185Operating income, Q1 FY2026, three months to 2026-03-31$184.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure288Operating income, Q2 FY2026, three months to 2026-06-30$287.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Interest expense$m4.5Interest expense, Q3 FY2023, three months to 2023-09-30$4.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure5.2Interest expense, Q4 FY2023, three months to 2023-12-31$5.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-20, accession 0001159036-24-000008. Derived: 12-month figure less the 9-month figure.Report this figure4.5Interest expense, Q1 FY2024, three months to 2024-03-31$4.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure4.5Interest expense, Q2 FY2024, three months to 2024-06-30$4.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure4.5Interest expense, Q3 FY2024, three months to 2024-09-30$4.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure4.5Interest expense, Q4 FY2024, three months to 2024-12-31$4.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure4.5Interest expense, Q1 FY2025, three months to 2025-03-31$4.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure4.4Interest expense, Q2 FY2025, three months to 2025-06-30$4.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure4.3Interest expense, Q3 FY2025, three months to 2025-09-30$4.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure4.9Interest expense, Q4 FY2025, three months to 2025-12-31$4.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure5.5Interest expense, Q1 FY2026, three months to 2026-03-31$5.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure5.6Interest expense, Q2 FY2026, three months to 2026-06-30$5.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Income tax$m19.9Income tax, Q3 FY2023, three months to 2023-09-30$19.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure15.8Income tax, Q4 FY2023, three months to 2023-12-31$15.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure19.2Income tax, Q1 FY2024, three months to 2024-03-31$19.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure24.5Income tax, Q2 FY2024, three months to 2024-06-30$24.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure28.1Income tax, Q3 FY2024, three months to 2024-09-30$28.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure41.2Income tax, Q4 FY2024, three months to 2024-12-31$41.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure25.7Income tax, Q1 FY2025, three months to 2025-03-31$25.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure39.8Income tax, Q2 FY2025, three months to 2025-06-30$39.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure43.7Income tax, Q3 FY2025, three months to 2025-09-30$43.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure40.7Income tax, Q4 FY2025, three months to 2025-12-31$40.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure30.3Income tax, Q1 FY2026, three months to 2026-03-31$30.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure55.0Income tax, Q2 FY2026, three months to 2026-06-30$55.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Net income$m81.8Net income, Q3 FY2023, three months to 2023-09-30$81.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure85.4Net income, Q4 FY2023, three months to 2023-12-31$85.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure76.8Net income, Q1 FY2024, three months to 2024-03-31$76.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure93.2Net income, Q2 FY2024, three months to 2024-06-30$93.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure137Net income, Q3 FY2024, three months to 2024-09-30$137.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure137Net income, Q4 FY2024, three months to 2024-12-31$137.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure118Net income, Q1 FY2025, three months to 2025-03-31$118.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure165Net income, Q2 FY2025, three months to 2025-06-30$165.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure175Net income, Q3 FY2025, three months to 2025-09-30$175.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure(142)Net income, Q4 FY2025, three months to 2025-12-31−$141.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure150Net income, Q1 FY2026, three months to 2026-03-31$150.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure230Net income, Q2 FY2026, three months to 2026-06-30$229.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Diluted EPS$ per share0.61Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figurenot reported0.60Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure0.72Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure1.05Diluted EPS, Q3 FY2024, three months to 2024-09-30$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figurenot reported0.93Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure1.33Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure1.43Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figurenot reported1.22Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure1.90Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Basic EPS$ per share0.62Basic EPS, Q3 FY2023, three months to 2023-09-30$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figurenot reported0.61Basic EPS, Q1 FY2024, three months to 2024-03-31$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure0.73Basic EPS, Q2 FY2024, three months to 2024-06-30$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure1.08Basic EPS, Q3 FY2024, three months to 2024-09-30$1.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figurenot reported0.96Basic EPS, Q1 FY2025, three months to 2025-03-31$0.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure1.36Basic EPS, Q2 FY2025, three months to 2025-06-30$1.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure1.49Basic EPS, Q3 FY2025, three months to 2025-09-30$1.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figurenot reported1.27Basic EPS, Q1 FY2026, three months to 2026-03-31$1.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure1.96Basic EPS, Q2 FY2026, three months to 2026-06-30$1.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure

Balance sheet

Cash and equivalents$163.1m, Q2 FY2026
Long-term debt$1.94bn, Q2 FY2026
Shareholders' equity$143.5m, Q2 FY2026
Halozyme Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m274Cash and equivalents, Q3 FY2023, at 2023-09-30$274.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure118Cash and equivalents, FY2023, at 2023-12-31$118.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure165Cash and equivalents, Q1 FY2024, at 2024-03-31$164.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure188Cash and equivalents, Q2 FY2024, at 2024-06-30$187.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure154Cash and equivalents, Q3 FY2024, at 2024-09-30$154.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure116Cash and equivalents, FY2024, at 2024-12-31$115.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure176Cash and equivalents, Q1 FY2025, at 2025-03-31$176.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure61.9Cash and equivalents, Q2 FY2025, at 2025-06-30$61.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure420Cash and equivalents, Q3 FY2025, at 2025-09-30$419.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure134Cash and equivalents, FY2025, at 2025-12-31$133.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure310Cash and equivalents, Q1 FY2026, at 2026-03-31$309.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure163Cash and equivalents, Q2 FY2026, at 2026-06-30$163.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Current assets$m879Current assets, Q3 FY2023, at 2023-09-30$879.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure746Current assets, FY2023, at 2023-12-31$746.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0001159036-25-000010.Report this figure874Current assets, Q1 FY2024, at 2024-03-31$873.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure988Current assets, Q2 FY2024, at 2024-06-30$987.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure1,127Current assets, Q3 FY2024, at 2024-09-30$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure1,085Current assets, FY2024, at 2024-12-31$1.09bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure1,262Current assets, Q1 FY2025, at 2025-03-31$1.26bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure1,123Current assets, Q2 FY2025, at 2025-06-30$1.12bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure1,329Current assets, Q3 FY2025, at 2025-09-30$1.33bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure825Current assets, FY2025, at 2025-12-31$825.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure1,003Current assets, Q1 FY2026, at 2026-03-31$1.00bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure933Current assets, Q2 FY2026, at 2026-06-30$933.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Total assets$m1,893Total assets, Q3 FY2023, at 2023-09-30$1.89bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure1,733Total assets, FY2023, at 2023-12-31$1.73bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0001159036-25-000010.Report this figure1,842Total assets, Q1 FY2024, at 2024-03-31$1.84bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure1,969Total assets, Q2 FY2024, at 2024-06-30$1.97bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure2,118Total assets, Q3 FY2024, at 2024-09-30$2.12bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure2,063Total assets, FY2024, at 2024-12-31$2.06bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure2,197Total assets, Q1 FY2025, at 2025-03-31$2.20bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure2,054Total assets, Q2 FY2025, at 2025-06-30$2.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure2,221Total assets, Q3 FY2025, at 2025-09-30$2.22bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure2,525Total assets, FY2025, at 2025-12-31$2.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure2,673Total assets, Q1 FY2026, at 2026-03-31$2.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure2,577Total assets, Q2 FY2026, at 2026-06-30$2.58bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Current liabilities$m115Current liabilities, Q3 FY2023, at 2023-09-30$115.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure112Current liabilities, FY2023, at 2023-12-31$112.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0001159036-25-000010.Report this figure132Current liabilities, Q1 FY2024, at 2024-03-31$131.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure133Current liabilities, Q2 FY2024, at 2024-06-30$133.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure109Current liabilities, Q3 FY2024, at 2024-09-30$108.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure139Current liabilities, FY2024, at 2024-12-31$139.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure150Current liabilities, Q1 FY2025, at 2025-03-31$150.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure134Current liabilities, Q2 FY2025, at 2025-06-30$134.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure837Current liabilities, Q3 FY2025, at 2025-09-30$837.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure177Current liabilities, FY2025, at 2025-12-31$177.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure363Current liabilities, Q1 FY2026, at 2026-03-31$363.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure344Current liabilities, Q2 FY2026, at 2026-06-30$344.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Total liabilities$m1,643Total liabilities, Q3 FY2023, at 2023-09-30$1.64bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure1,649Total liabilities, FY2023, at 2023-12-31$1.65bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-18, accession 0001159036-25-000010.Report this figure1,664Total liabilities, Q1 FY2024, at 2024-03-31$1.66bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure1,680Total liabilities, Q2 FY2024, at 2024-06-30$1.68bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure1,665Total liabilities, Q3 FY2024, at 2024-09-30$1.67bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure1,700Total liabilities, FY2024, at 2024-12-31$1.70bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure1,714Total liabilities, Q1 FY2025, at 2025-03-31$1.71bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure1,721Total liabilities, Q2 FY2025, at 2025-06-30$1.72bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure1,717Total liabilities, Q3 FY2025, at 2025-09-30$1.72bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure2,477Total liabilities, FY2025, at 2025-12-31$2.48bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure2,453Total liabilities, Q1 FY2026, at 2026-03-31$2.45bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure2,434Total liabilities, Q2 FY2026, at 2026-06-30$2.43bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Long-term debt$m1,498Long-term debt, Q3 FY2023, at 2023-09-30$1.50bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure1,499Long-term debt, FY2023, at 2023-12-31$1.50bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-18, accession 0001159036-25-000010.Report this figure1,501Long-term debt, Q1 FY2024, at 2024-03-31$1.50bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure1,503Long-term debt, Q2 FY2024, at 2024-06-30$1.50bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure1,504Long-term debt, Q3 FY2024, at 2024-09-30$1.50bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure1,506Long-term debt, FY2024, at 2024-12-31$1.51bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure1,507Long-term debt, Q1 FY2025, at 2025-03-31$1.51bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure1,509Long-term debt, Q2 FY2025, at 2025-06-30$1.51bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure800Long-term debt, Q3 FY2025, at 2025-09-30$800.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure2,143Long-term debt, FY2025, at 2025-12-31$2.14bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure1,936Long-term debt, Q1 FY2026, at 2026-03-31$1.94bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure1,938Long-term debt, Q2 FY2026, at 2026-06-30$1.94bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Current portion of debt$m0.0Current portion of debt, Q3 FY2023, at 2023-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2024-02-20, accession 0001159036-24-000008.Report this figurenot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figurenot reportednot reported711Current portion of debt, Q3 FY2025, at 2025-09-30$710.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure209Current portion of debt, Q1 FY2026, at 2026-03-31$208.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure209Current portion of debt, Q2 FY2026, at 2026-06-30$209.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure
Shareholders' equity$m249Shareholders' equity, Q3 FY2023, at 2023-09-30$249.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure83.8Shareholders' equity, FY2023, at 2023-12-31$83.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0001159036-26-000024.Report this figure178Shareholders' equity, Q1 FY2024, at 2024-03-31$177.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure289Shareholders' equity, Q2 FY2024, at 2024-06-30$289.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure453Shareholders' equity, Q3 FY2024, at 2024-09-30$452.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure364Shareholders' equity, FY2024, at 2024-12-31$363.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure482Shareholders' equity, Q1 FY2025, at 2025-03-31$482.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure333Shareholders' equity, Q2 FY2025, at 2025-06-30$332.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure504Shareholders' equity, Q3 FY2025, at 2025-09-30$503.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure48.8Shareholders' equity, FY2025, at 2025-12-31$48.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure220Shareholders' equity, Q1 FY2026, at 2026-03-31$219.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure144Shareholders' equity, Q2 FY2026, at 2026-06-30$143.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure

Cash flow

Operating cash flow$240.9m, Q2 FY2026
Capital expenditure$4.2m, Q2 FY2026
Share repurchases$0, Q4 FY2025
Halozyme Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m132Operating cash flow, Q3 FY2023, three months to 2023-09-30$132.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001159036-24-000050. Derived: 9-month figure less the 6-month figure.Report this figure102Operating cash flow, Q4 FY2023, three months to 2023-12-31$102.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure129Operating cash flow, Q1 FY2024, three months to 2024-03-31$129.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure55.8Operating cash flow, Q2 FY2024, three months to 2024-06-30$55.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001159036-25-000034. Derived: 6-month figure less the 3-month figure.Report this figure115Operating cash flow, Q3 FY2024, three months to 2024-09-30$115.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001159036-25-000045. Derived: 9-month figure less the 6-month figure.Report this figure178Operating cash flow, Q4 FY2024, three months to 2024-12-31$178.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure154Operating cash flow, Q1 FY2025, three months to 2025-03-31$154.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure99.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$99.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001159036-26-000104. Derived: 6-month figure less the 3-month figure.Report this figure179Operating cash flow, Q3 FY2025, three months to 2025-09-30$178.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001159036-25-000045. Derived: 9-month figure less the 6-month figure.Report this figure219Operating cash flow, Q4 FY2025, three months to 2025-12-31$219.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure180Operating cash flow, Q1 FY2026, three months to 2026-03-31$180.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure241Operating cash flow, Q2 FY2026, three months to 2026-06-30$240.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001159036-26-000104. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m2.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-31, accession 0001159036-24-000050. Derived: 9-month figure less the 6-month figure.Report this figure2.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure3.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$3.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure2.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001159036-25-000034. Derived: 6-month figure less the 3-month figure.Report this figure1.5Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001159036-25-000045. Derived: 9-month figure less the 6-month figure.Report this figure3.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$950.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure1.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001159036-26-000104. Derived: 6-month figure less the 3-month figure.Report this figure3.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001159036-25-000045. Derived: 9-month figure less the 6-month figure.Report this figure1.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure3.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure4.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001159036-26-000104. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-31, accession 0001159036-24-000050. Derived: 9-month figure less the 6-month figure.Report this figure252Share repurchases, Q4 FY2023, three months to 2023-12-31$252.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-05, accession 0001159036-25-000034. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-03, accession 0001159036-25-000045. Derived: 9-month figure less the 6-month figure.Report this figure250Share repurchases, Q4 FY2024, three months to 2024-12-31$250.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported38.9Share repurchases, Q3 FY2025, three months to 2025-09-30$38.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-03, accession 0001159036-25-000045. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0001159036-26-000024. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)121.22m, Q2 FY2026
Halozyme Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares139Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30139,387,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001159036-23-000057.Report this figure138Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31137,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001159036-24-000037.Report this figure134Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30133,543,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001159036-24-000044.Report this figure134Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30134,083,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001159036-24-000050.Report this figure129Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31128,887,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001159036-25-000026.Report this figure129Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30129,222,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001159036-25-000034.Report this figure130Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30130,134,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure127Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31126,644,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure124Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30124,158,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure122Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30122,331,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001159036-25-000045.Report this figure123Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31122,875,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001159036-26-000068.Report this figure121Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30121,215,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure

Shares outstanding: 113.50mShares outstanding, period not labelled, at 2026-07-31113,498,000 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001159036-26-000104.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.